Do not take without water
[41], GLP-1 receptor agonists represent a promising adjunct to BS in pediatric populations, with Semaglutide demonstrating superior efficacy in recent trials
We may see product reformulations or incumbents investing in healthier categories with higher protein, as users demand fewer meals and seek nutrient-dense options when they do eat
Data shows that 1.6 million adults in England, Wales, and Scotland used a GLP-1 medication for weight loss between 2024 and 2025
Milliner, D., Hoppe, B
In India, the price differential between the off-patent and original brands may be small, given existing aggressive pricing, and so robust RWE studies could give a differentiating edge, especially for companies developing oral semaglutide where the existing market is less established